I sent email inquiry to Matt this am to address whether the trials are blind. I'm sure matt would not mind me sharing his response w/ this board. The following is what I sent him and his response:

From Me:

Hi Matt,

Usually I ask questions you can't answer due to inside info. But here is one I think you can answer: Are the current Afrezza trials "blind" or is management aware of the results as patients complete their participation in the trial? The reason I am asking is to determine whether this info is available to MNKD to use in forward strategic planning and partner negotiations.

From Matt:

"Blind, sorry to say, so we do not know anyhing about the results (well, not efficay) until they are done."